Split-personality inhibitors
June 24th, 2021 by Carson C. Thoreen
Nature Chemical Biology, Published online: 24 June 2021; doi:10.1038/s41589-021-00820-8
A rationally designed class of mTORC1 inhibitors combines the selectivity of rapamycin with the potency of mTOR kinase inhibitors.